Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Contemp Clin Trials. 2010 Jul 30;31(6):589–603. doi: 10.1016/j.cct.2010.07.012

Table 4b.

Psychosocial Scale Scores among 1,252 study participants randomly selected to complete the supplementary SOS Long Survey

Group 1 Group 2 Group 3 Group 4
UC UC + Auto UC + Auto + Assisted UC + Auto + Assisted + Care Mgt
Characteristics n=321 n=349 n=285 n=297
Self Efficacy Scale, mean (sd) 4.3 (0.8) 4.3 (0.8) 4.2 (0.8) 4.3 (0.8)
    (missing) 1 1 1 0
CRC Screening Cons Scale, mean (sd) 1.8 (0.7) 1.7 (0.7) 1.9 (0.8) 1.7 (0.7)
    (missing) 1 1 1 0
CRC Screening Pros Scale, mean (sd) 4.5 (0.6) 4.6 (0.5) 4.4 (0.6) 4.5 (0.6)
    (missing) 1 0 1 0
Social Influence Scale, mean (sd) 3.7 (1.1) 3.9 (0.9) 3.6 (1.1) 3.6 (1.0)
    (missing) 5 8 10 8
Cancer Worries Scale, mean (sd) 2.3 (0.8) 2.2 (0.8) 2.2 (0.7) 2.2 (0.7)
    (missing) 1 0 1 1

All scales range from 1 to 5, with higher scores associated with stronger endorsement of self-efficacy, screening cons, screening pros, social influence, and cancer worries.